Structure of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7

Iden­ti­fi­ca­tion

CAS Number

1062122-63-7

Name

Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95)

Syn­onyms

(2S)-1-{(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3 ,5,7,15,19-docosapentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-ylacetyl}-2-piperidincarbonsäure [Ger­man] [ACD/IUPAC Name]
(2S)-1-{(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3 ,5,7,15,19-docosapentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-ylacetyl}-2-piperidinecarboxylic acid [ACD/IUPAC Name]
2-Piperidinecar­boxylic acid, 1-[1,2-dioxo-2-[(2R,3R,6S)-tetrahy­dro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dim ethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]ethyl]-, (2S)- [ACD/​Index Name]
Acide (2S)-1-{2-[(2R,3R,6S)-2-hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyéthoxy)-3-méthoxycyclohexyl]-2,13-diméthoxy-3,9,11,15,17,21-hexaméthyl-12,18 -dioxo-3,5,7,15,19-docosapentaén-1-yl}-3-méthyltétrahydro-2H-pyran-2-yl]-2-oxoacétyl}-2-pipéridinecarboxylique [French] [ACD/IUPAC Name]
(2S)?-1-?[2-?oxo-?2-?[(2R,?3R,?6S)?-?tetrahydro-?2-?hydroxy-?6-?[(2S,?3E,?5E,?7E,?9S,?11R,?13R,?14R,?15E,?17R,?19E,?21R)?-?14-?hydroxy-?22-?[(1S,?3R,?4R)?-?4-?(2-?hydroxyethoxy)?-?3-?methoxycyclohexyl]?-?2,?13-?dimethoxy-?3,?9,?11,?15,?17,?21-?hexamethyl-?12,?18-?dioxo-?3,?5,?7,?15,?19-?docosapentaen-?1-?yl]?-?3-?methyl-?2H-?pyran-?2-?yl]?acetyl]?-?2-?Piperidinecarboxylic acid
1062122-63-7 [RN]

SMILES

C[C@@H]1CC[C@H](O[C@]1(C(=O)C(=O)N2CCCC[C@H]2C(=O)O)O)C[C@@H](/C(=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@@H]([C@@H](/C(=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]3CC[C@H]([C@@H](C3)OC)OCCO)/C)O)OC)/C)OC

Std­InChI

InChI=1S/C53H83NO14/c1-33(16-12-11-13-17-35(3)45(64-8)32-41-22-20-39(7)53(63,68-41)50(59)51(60)54-25-15-14-18-42(54)52(61)62)28-37(5)47(57)49(66-10)48(58)38(6)30-36(4)43(56)23-19-34(2)29-40-21-24-44(67-27-26-55)46(31-40)65-9/h11-13,16-17,19,23,30,33-34,36-37,39-42,44-46,48-49,55,58,63H,14-15,18,20-22,24-29,31-32H2,1-10H3,(H,61,62)/b13-11+,16-12+,23-19+,35-17+,38-30+/t33-,34+,36-,37-,39-,40+,41+,42+,44-,45+,46-,48-,49+,53-/m1/s1

Std­InChIKey

PRSJHEVLVQFMHJ-FRLQEAC­C­SA-N

Mol­e­c­u­lar Formula

C53H83NO14

Mol­e­c­u­lar Weight

958.224

Prop­er­ties

Appear­ance

White sol­id

Safe­ty Data

WGK Germany

3

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7

Iden­ti­fi­ca­tion Methods

HNMR, HPLC

Puri­ty

≥95%

Shelf Life

2 years

Stor­age

Store at 2-8℃, sealed and away from light.

Known Appli­ca­tion

Often used as an impu­ri­ty for Everolimus.

Gen­er­al View of Documents

HNMR 1 of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HNMR-1 of Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HNMR 2 of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HNMR-2 of Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HNMR 3 of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HNMR-3 of Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HNMR 4 of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HNMR-4 of Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
MS 1 of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
MS-1 of Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
MS 2 of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
MS-2 of Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
TG of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
TG of Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HPLC of Everolimus Impurity Everolimus 19 ene open ring804 95 CAS 1062122 63 7 - Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7
HPLC of Everolimus Impu­ri­ty Everolimus-19-ene open ring(804-95) CAS 1062122-63-7

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd (https://​www​.cam​ing​.com/).

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly.

























    Please prove you are human by select­ing the Heart.